EATRIS is at the forefront of advancing scientific innovations across translational medicine fields. We specialise in five platforms, each catering to distinct areas needed for product development processes:
- Advanced Therapies Medicinal Products
- Biomarkers
- Imaging and Tracing
- Small Molecules
- Vaccines, Inflammation and Immune Monitoring.
Member institutions within EATRIS are provided with the opportunity to align with one or more of these platforms, fostering targeted scientific collaboration. Each platform offers a specific set of infrastructure services targeted to the needs of its users (industry, academia, charity funders and governments). EATRIS Scientific platforms are composed of academic and non-profit research institutions in biomedical translational research. All members possess well-established track records in entering clinical development, state-of-the-art technology platform and know-how, hosting unique infrastructures, licenses (such as Good Manufacturing Practice (GMP) laboratories), and clinical expertise with access to a broad array of patient cohorts.
Click on one of the tiles to find an overview of the services and technologies available for the platform.
